Back to Trades
Reardon Andrew
CLO & SecretaryCIK 0001950232
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 54
- Companies
- 1
- Active
- 2025–2026
Across 8 filings between 2025–2026, Reardon Andrew, CLO & Secretary, has disclosed $12.1M in transactions — all concentrated in LIGAND PHARMACEUTICALS INC (LGND). Their disclosed trades are heavily weighted toward selling — $0 in buys and $8.8M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Sep 8 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | Sell | $1.4M |
| Aug 4 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | Sell | $1.4M |
| Jul 6 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | Sell | $1.6M |
| Jun 2 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | Sell | $1.1M |
| May 4 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | Sell | $1.2M |
| Apr 2 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | Sell | $1.0M |
| Mar 6 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | Sell | $1.0M |
| Aug 12 | LGND LIGAND PHARMACEUTICALS INC | Reardon Andrew | CLO & Secretary | Tax withheld | $198.8K |
8 filings